The risk markers with the largest variability across outcomes were discontinued status (i.e., withdrawal from hemodialysis), number of sessions in the previous month, claim for atherosclerotic heart disease, claim for peripheral vascular disease, and serum albumin level. The gene discussed is ALB; the disease is peripheral vascular disease.